PROCTER & GAMBLE HEALTH | BDH INDUS. | PROCTER & GAMBLE HEALTH/ BDH INDUS. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 37.3 | 21.6 | 173.1% | View Chart |
P/BV | x | 10.7 | 3.5 | 309.3% | View Chart |
Dividend Yield | % | 2.0 | 1.2 | 162.9% |
PROCTER & GAMBLE HEALTH BDH INDUS. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
BDH INDUS. Mar-23 |
PROCTER & GAMBLE HEALTH/ BDH INDUS. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 211 | 2,539.9% | |
Low | Rs | 3,883 | 93 | 4,197.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 129.3 | 573.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 14.2 | 970.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 15.2 | 1,018.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 4.00 | 2,375.0% | |
Avg Dividend yield | % | 2.1 | 2.6 | 78.0% | |
Book value per share (Unadj.) | Rs | 447.6 | 95.0 | 471.4% | |
Shares outstanding (eoy) | m | 16.60 | 5.76 | 288.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.2 | 531.6% | |
Avg P/E ratio | x | 33.5 | 10.7 | 313.9% | |
P/CF ratio (eoy) | x | 29.8 | 10.0 | 299.0% | |
Price / Book Value ratio | x | 10.3 | 1.6 | 646.2% | |
Dividend payout | % | 68.7 | 28.1 | 244.8% | |
Avg Mkt Cap | Rs m | 76,761 | 874 | 8,778.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 70 | 2,963.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 745 | 1,651.4% | |
Other income | Rs m | 184 | 8 | 2,186.7% | |
Total revenues | Rs m | 12,480 | 753 | 1,657.4% | |
Gross profit | Rs m | 3,247 | 110 | 2,964.3% | |
Depreciation | Rs m | 281 | 6 | 4,938.5% | |
Interest | Rs m | 8 | 2 | 487.3% | |
Profit before tax | Rs m | 3,142 | 111 | 2,838.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 29 | 2,959.5% | |
Profit after tax | Rs m | 2,295 | 82 | 2,796.7% | |
Gross profit margin | % | 26.4 | 14.7 | 179.5% | |
Effective tax rate | % | 27.0 | 25.9 | 104.3% | |
Net profit margin | % | 18.7 | 11.0 | 169.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 605 | 1,936.6% | |
Current liabilities | Rs m | 6,791 | 246 | 2,759.3% | |
Net working cap to sales | % | 40.0 | 48.2 | 83.1% | |
Current ratio | x | 1.7 | 2.5 | 70.2% | |
Inventory Days | Days | 263 | 3 | 10,457.1% | |
Debtors Days | Days | 343 | 816 | 42.1% | |
Net fixed assets | Rs m | 10,617 | 195 | 5,432.3% | |
Share capital | Rs m | 166 | 58 | 288.3% | |
"Free" reserves | Rs m | 7,265 | 489 | 1,484.5% | |
Net worth | Rs m | 7,431 | 547 | 1,358.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 800 | 2,790.3% | |
Interest coverage | x | 409.1 | 71.1 | 575.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.9 | 59.2% | |
Return on assets | % | 10.3 | 10.4 | 98.7% | |
Return on equity | % | 30.9 | 15.0 | 205.9% | |
Return on capital | % | 42.4 | 20.5 | 206.5% | |
Exports to sales | % | 0 | 51.7 | 0.0% | |
Imports to sales | % | 13.1 | 29.7 | 43.9% | |
Exports (fob) | Rs m | NA | 385 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 221 | 725.4% | |
Fx inflow | Rs m | 1,465 | 385 | 380.9% | |
Fx outflow | Rs m | 1,605 | 221 | 725.4% | |
Net fx | Rs m | -140 | 163 | -85.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 63 | 3,749.6% | |
From Investments | Rs m | -215 | 5 | -4,414.8% | |
From Financial Activity | Rs m | -985 | 4 | -26,978.1% | |
Net Cashflow | Rs m | 1,160 | 71 | 1,623.7% |
Indian Promoters | % | 0.0 | 41.6 | - | |
Foreign collaborators | % | 51.8 | 8.1 | 642.1% | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 50.3 | 95.7% | |
Shareholders | 56,778 | 5,432 | 1,045.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | BDH INDUS. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -2.16% | 0.52% | 0.31% |
1-Month | 1.11% | 13.60% | 0.08% |
1-Year | 3.34% | 145.35% | 54.11% |
3-Year CAGR | -8.55% | 51.55% | 14.46% |
5-Year CAGR | 5.46% | 34.13% | 20.04% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the BDH INDUS. share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of BDH INDUS. the stake stands at 49.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of BDH INDUS..
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
BDH INDUS. paid Rs 4.0, and its dividend payout ratio stood at 28.1%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of BDH INDUS..
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended higher.